TEKAGRA

This brand name is authorized in Nigeria.

Active ingredients

The drug TEKAGRA contains one active pharmaceutical ingredient (API):

1	Sildenafil UNII BW9B0ZE037 - SILDENAFIL CITRATE
	Sildenafil is a potent and selective inhibitor of cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5), the enzyme that is responsible for degradation of cGMP. Apart from the presence of this enzyme in the corpus cavernosum of the penis, PDE5 is also present in the pulmonary vasculature. Sildenafil, therefore, increases cGMP within pulmonary vascular smooth muscle cells resulting in relaxation.
	Read more about Sildenafil

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-3634	Tablet	Tekagra 100 Tablets TAB 100 mg		30/11/2020
B4-6967	Tablet	TEKAGRA ORAL JELLY (ORANGE FLAVOUR) TAB 100 mg 4X1X5G, 7X1X5G	10 RNW-PP-259161 TEKAGRA ORAL JELLY (ORANGE FLAVOUR) SILDENAFIL ORAL JELLY 100MG SILDENAFIL CITRATE 100MG, METHYLPARABEN SODIUM, PROPYLPARABEN SODIUM, ACESULFAME POTASSIUM, SODIUM CHLORIDE, PRPYLENE GLYCOL, SORBITOL, SODIUM CARBOXYMETHYLCELLULOSE, CITRIC ACID, SUNSET YELLOW, PURIFIED WATER, SUCROSE, ORANGE M3398 FLAVORANT, ORANGE JUICY M7031 B4-6967 Drugs Imported Products 4X1X5G,7X1X5G POM 1 6/24/2023 TEKA PHARMACEUTICALCOMPANY LTD, ,ZUNGERU ROAD, NOMANSLAND KANO KANO 7066430624 tekapharmaceuticalco@outlook.com NAVKETAN PHARMA PVT LIMITED F-106 MIDC AREA, WALUJ, DIST, AURANGABAD.431 136 (M.S) INDIA, PLOT NO. F-106,M.I.D.C, WALUJ, AURANGABAD-431136 MAHARASHTRA STATE, INDIA, India	31/10/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
G04BE03	Sildenafil	G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction
Discover more medicines within G04BE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-3634, B4-6967